Hypertrabeculation with heart failure (formally known as NCCMP)
Hypertrabeculation in athletes/African-american vs CKD/HTN vs heart failure patients with hypertrabeculation, formerly described as LVNC/NCCMP (systole NC/C 2:1 apical, >4 prominent trabecula apically and many more)
GLS -15,4% as cut-off for pathological hypertrabeculation in normal EF (vs. -18,9% control group)
Additionally: Rigid body rotation 57% in hypertrabeculation vs 14% healthy individuals
Base to Apex Gradient in hypertrabeculation with HF, moderately reduced GLS, reduced LA Strain
Base to Apex Gradient in hypertrabeculation with HF, moderately reduced GLS, reduced LA Strain
In the follow-up improvement of the GLS, a borderline normal FWS, normalisation of LA Strain
In the follow-up improvement of the GLS, a borderline normal FWS, normalisation of LA Strain
Hypertrabeculation with heart failure & GDMT effect
The Evolution of strain
Hypertrabeculation without heart failure
Low-normal GLS, normal Dispersion, no relevant PSI, GLS as baseline
Low-normal GLS, normal Dispersion, no relevant PSI, GLS as baseline
Normal atrial strain in hypertrabeculation without heart failure
Normal atrial strain in hypertrabeculation without heart failure
